These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 23720768)

  • 1. TLR4 is a novel determinant of the response to paclitaxel in breast cancer.
    Rajput S; Volk-Draper LD; Ran S
    Mol Cancer Ther; 2013 Aug; 12(8):1676-87. PubMed ID: 23720768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Administration with hyperoside sensitizes breast cancer cells to paclitaxel by blocking the TLR4 signaling.
    Sun T; Liu Y; Li M; Yu H; Piao H
    Mol Cell Probes; 2020 Oct; 53():101602. PubMed ID: 32447047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BRCA1-IRIS inactivation overcomes paclitaxel resistance in triple negative breast cancers.
    Blanchard Z; Paul BT; Craft B; ElShamy WM
    Breast Cancer Res; 2015 Jan; 17(1):5. PubMed ID: 25583261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TLR4 signaling induced by lipopolysaccharide or paclitaxel regulates tumor survival and chemoresistance in ovarian cancer.
    Szajnik M; Szczepanski MJ; Czystowska M; Elishaev E; Mandapathil M; Nowak-Markwitz E; Spaczynski M; Whiteside TL
    Oncogene; 2009 Dec; 28(49):4353-63. PubMed ID: 19826413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compound A attenuates toll-like receptor 4-mediated paclitaxel resistance in breast cancer and melanoma through suppression of IL-8.
    Sootichote R; Thuwajit P; Singsuksawat E; Warnnissorn M; Yenchitsomanus PT; Ithimakin S; Chantharasamee J; Thuwajit C
    BMC Cancer; 2018 Feb; 18(1):231. PubMed ID: 29486738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological and small interference RNA-mediated inhibition of breast cancer-associated fatty acid synthase (oncogenic antigen-519) synergistically enhances Taxol (paclitaxel)-induced cytotoxicity.
    Menendez JA; Vellon L; Colomer R; Lupu R
    Int J Cancer; 2005 May; 115(1):19-35. PubMed ID: 15657900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Galectin-3 induces ovarian cancer cell survival and chemoresistance via TLR4 signaling activation.
    Cai G; Ma X; Chen B; Huang Y; Liu S; Yang H; Zou W
    Tumour Biol; 2016 Sep; 37(9):11883-11891. PubMed ID: 27059733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the TLR4-androgen receptor axis and genistein in taxol-resistant ovarian cancer cells.
    Huang SL; Chang TC; Chao CCK; Sun NK
    Biochem Pharmacol; 2020 Jul; 177():113965. PubMed ID: 32278794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal stem cells drive paclitaxel resistance in ErbB2/ErbB3-coexpressing breast cancer cells via paracrine of neuregulin 1.
    Chen J; Ren Q; Cai Y; Lin T; Zuo W; Wang J; Lin R; Zhu L; Wang P; Dong H; Zhao H; Huang L; Fu Y; Yang S; Tan J; Lan X; Wang S
    Biochem Biophys Res Commun; 2018 Jun; 501(1):212-219. PubMed ID: 29715459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased expression of MyD88 and association with paclitaxel resistance in breast cancer.
    Xiang F; Ni Z; Zhan Y; Kong Q; Xu J; Jiang J; Wu R; Kang X
    Tumour Biol; 2016 May; 37(5):6017-25. PubMed ID: 26596839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toll-like receptor 4 ligation confers chemoresistance to docetaxel on PC-3 human prostate cancer cells.
    Zhang Y; Wang Y; Yuan J; Qin W; Liu F; Wang F; Zhang G; Yang X
    Cell Biol Toxicol; 2012 Aug; 28(4):269-77. PubMed ID: 22648782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paclitaxel resistance is associated with switch from apoptotic to autophagic cell death in MCF-7 breast cancer cells.
    Ajabnoor GM; Crook T; Coley HM
    Cell Death Dis; 2012 Jan; 3(1):e260. PubMed ID: 22278287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of centrosomal protein Nlp confers breast carcinoma resistance to paclitaxel.
    Zhao W; Song Y; Xu B; Zhan Q
    Cancer Biol Ther; 2012 Feb; 13(3):156-63. PubMed ID: 22353935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TLR4 and NFκB signaling is critical for taxol resistance in ovarian carcinoma cells.
    Sun NK; Huang SL; Chang TC; Chao CC
    J Cell Physiol; 2018 Mar; 233(3):2489-2501. PubMed ID: 28771725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paclitaxel therapy promotes breast cancer metastasis in a TLR4-dependent manner.
    Volk-Draper L; Hall K; Griggs C; Rajput S; Kohio P; DeNardo D; Ran S
    Cancer Res; 2014 Oct; 74(19):5421-34. PubMed ID: 25274031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of the MAD2-TLR4-MyD88 axis in paclitaxel resistance in ovarian cancer.
    Bates M; Spillane CD; Gallagher MF; McCann A; Martin C; Blackshields G; Keegan H; Gubbins L; Brooks R; Brooks D; Selemidis S; O'Toole S; O'Leary JJ
    PLoS One; 2020; 15(12):e0243715. PubMed ID: 33370338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TLR4 Promotes Breast Cancer Metastasis via Akt/GSK3β/β-Catenin Pathway upon LPS Stimulation.
    Li J; Yin J; Shen W; Gao R; Liu Y; Chen Y; Li X; Liu C; Xiang R; Luo N
    Anat Rec (Hoboken); 2017 Jul; 300(7):1219-1229. PubMed ID: 28296189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated expression of erbB3 confers paclitaxel resistance in erbB2-overexpressing breast cancer cells via upregulation of Survivin.
    Wang S; Huang X; Lee CK; Liu B
    Oncogene; 2010 Jul; 29(29):4225-36. PubMed ID: 20498641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockade of TLR4 using TAK-242 (resatorvid) enhances anti-cancer effects of chemotherapeutic agents: a novel synergistic approach for breast and ovarian cancers.
    Kashani B; Zandi Z; Karimzadeh MR; Bashash D; Nasrollahzadeh A; Ghaffari SH
    Immunol Res; 2019 Dec; 67(6):505-516. PubMed ID: 32026322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucocorticoid receptor-induced MAPK phosphatase-1 (MPK-1) expression inhibits paclitaxel-associated MAPK activation and contributes to breast cancer cell survival.
    Wu W; Pew T; Zou M; Pang D; Conzen SD
    J Biol Chem; 2005 Feb; 280(6):4117-24. PubMed ID: 15590693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.